Tirosint and Nasonex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tirosint (levothyroxine sodium) and Nasonex (mometasone furoate monohydrate). Common drug interactions include headache among females and osteopenia among males.

The phase IV clinical study analyzes what interactions people have when they take Tirosint and Nasonex. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Tirosint?

Tirosint has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 5,000 Tirosint users. Check the latest studies of Tirosint.

What is Nasonex?

Nasonex has active ingredients of mometasone furoate monohydrate. It is often used in allergies. eHealthMe is studying from 32,299 Nasonex users. Check the latest studies of Nasonex.

On Jul, 15, 2026

14 people who take Tirosint and Nasonex together, and have interactions are studied.

What are the common drug interactions of Tirosint and Nasonex, by gender? *:

female:

Headache (pain in head)
Influenza
Sinusitis (inflammation of sinus)
Abdominal discomfort
Application site erythema (redness of the skin at application site)
Application site pain
Application site paraesthesia (abnormal skin sensation of tingling, tickling, prickling, pricking, or burning felt at application site)
Application site pruritus (application site severe itching of the skin)
Blood pressure increased
Chest discomfort

male:

Osteopenia (a condition where bone mineral density is lower than normal)
Osteoporosis (bones weak and more likely to break)
Multiple fractures
Pain
Spinal fracture (fracture in one of vertebrae)
Tooth fracture
Tooth loss
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Bone density decreased

What are the common drug interactions of Tirosint and Nasonex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Headache (pain in head)
Osteopenia (a condition where bone mineral density is lower than normal)
Osteoporosis (bones weak and more likely to break)
Sinusitis (inflammation of sinus)
Abdominal discomfort
Abdominal pain
Abdominal tenderness
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Application site erythema (redness of the skin at application site)

60+:

Disturbance in attention
Dizziness
Urinary incontinence (inability to control the flow of urine and involuntary urination)
Vertigo
Dysgraphia (impaired ability to learn to write)
Headache (pain in head)
Initial insomnia (feeling of inadequate or poor-quality sleep)
Memory impairment
Micturition urgency (urgency to pass the urine)
Stress

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 64.29%
Migraine (headache): 2 people, 14.29%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 14.29%
Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 7.14%
Rickets (softening of bones): 1 person, 7.14%
Nausea (feeling of having an urge to vomit): 1 person, 7.14%
Infection: 1 person, 7.14%
Indigestion: 1 person, 7.14%
Hypersensitivity: 1 person, 7.14%
Hiv Infection: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Tirosint and Nasonex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously